Evrysdi (risdiplam) For recalls
The FDA has published 1 recall involving Evrysdi (risdiplam) For since 2021. The latest was reported on 5 May 2021. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls1since 2021
Last 12 months0reported
Class I00% of total
Ongoing0latest 5 May 2021
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 0 0%Class III 1 100%
Why evrysdi (risdiplam) for is recalled
Companies
By year
All evrysdi (risdiplam) for recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Evrysdi (risdiplam) for oral solution, 60 mg recalled by Genentech | Genentech | Other | Nationwide |
Should you stop taking Evrysdi (risdiplam) For?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.